Methods and compositions for the treatment of multiple sclerosis
AssigneeSymbionyx Pharmaceuticals Inc.
InventorsRatan K. Chaudhuri, Krzysztof Bojanowski
Life of this patent
Estimating the term…
Abstract
Compositions and methods based on isosorbide esters for the treatment of multiple sclerosis.
Claims24
A method of treating multiple sclerosis or the symptoms thereof said method comprising administering to the patient suffering therefrom a therapeutically effective amount of a compound according to Formula (I):
- in which R1 and R2 are both —C(O)CH═CH—C(O)OMe or one of R1 and R2 is H and the other —C(O)CH═CH—C(O)OMe, wherein Me is methyl.
A method of treating multiple sclerosis or the symptoms thereof said method comprising administering to the patient suffering therefrom a therapeutically effective amount of composition comprising at least one compound accordina to Formula (I):
- in which R1 and R2 are both —C(O)CH═CH—C(O)OMe or one of R1 and R2 is H and the other —C(O)CH═CH—C(O)OMe, wherein Me is methyl and a pharmaceutically acceptable vehicle.
A composition for use in the treatment of multiple sclerosis or the symptoms thereof said composition comprising administering to the patient suffering therefrom a therapeutically effective amount of composition comprising at least one compound according to Formula (I):
- in which R1 and R2 are both —C(O)CH═CH—C(O)OMe or one of R1 and R2 is H and the other —C(O)CH═CH—C(O)OMe, wherein Me is methyl, at least one other pharmaceutical active that reduces, ameliorates, inhibits or otherwise addresses or treats MS symptoms and/or conditions associated with MS and its concurrent diseases/maladies, and a pharmaceutically acceptable vehicle.
Dependencies are inferred from the claim text.